Aquatic Capital Management LLC Gilead Sciences, Inc. Transaction History

Aquatic Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$71.58 - $87.29 $16.3 Million - $19.9 Million	227,900 New	227,900 $16.7 Million
Q3 2023 Nov 14, 2023	BUY	$73.94 - $80.67 $3.41 Million - $3.72 Million	46,100 New	46,100 $3.46 Million
Q1 2022 May 16, 2022	SELL	$57.92 - $72.58 $167,968 - $210,482	-2,900 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$64.88 - $73.64 $188,152 - $213,556	2,900 New	2,900 $211,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Aquatic Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aquatic Capital Management LLC with notifications on news.